patent protection
Biosimilars: Prioritising the Emerging Market Opportunity
September 01 by Pharmaceuticals & Biotechnology EditorBy 2015, approximately USD73 billion of biologic sales are projected to lose patent protection, opening the door for the entry of biosimilar versions of these agents. The majority of agents losing p...
How Can Polymorph Patents Increase Cost Efficiency?
October 13 by Pharma IQMandar Kodgule, Head of Intellectual Property and Strategic Planning at Wockhardt, answers this question as well as offering the top five strategic considerations to sustain a healthy polymorph patent...
How Can Polymorph Patents Increase Cost Efficiency?
October 13 by Pharma IQ NewsPharma IQ have just made a great new podcast interview available on the Resource Centre; How can polymorph patents increase cost efficiency? The podcast is an interview with Mandar Kodgule, Head...
The Challenges of Patenting in Pharma: Interview with Eric Ruhlmann, Actelion Pharmaceuticals
March 29 by Eric RuhlmannEric Ruhlmann, European Patent Attorney Director, Senior Patent Counsel, Legal Department, Actelion Pharmaceuticals Ltd, joins Pharma IQ, to discuss the latest challenges for patenting pharmaceutic...